Connection
Michael Clay to Cyclin-Dependent Kinase Inhibitor p57
This is a "connection" page, showing publications Michael Clay has written about Cyclin-Dependent Kinase Inhibitor p57.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.037 |
|
|
|
-
Pinto EM, Rodriguez-Galindo C, Pounds SB, Wang L, Clay MR, Neale G, Garfinkle EAR, Lam CG, Levy CF, Pappo AS, Zambetti GP, Ribeiro RC. Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study. J Clin Oncol. 2017 Dec 10; 35(35):3956-3963.
Score: 0.037